雷尼替丁在结直肠癌肝转移患者中的随机安慰剂对照双盲试验:细胞介导免疫低下患者的生存优势

{"title":"雷尼替丁在结直肠癌肝转移患者中的随机安慰剂对照双盲试验:细胞介导免疫低下患者的生存优势","authors":"J. King, J. Caplehorn, J. Seifert, A. Preketes, P. Clingan, D. Morris","doi":"10.1080/14759560290032746","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":100490,"journal":{"name":"ESMO Gastrointestinal Oncology","volume":"91 6 1","pages":"39-44"},"PeriodicalIF":0.0000,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Randomised Placebo Control Double-blind Trial of Ranitidine in Patients with Colorectal Hepatic Metastases: Survival Advantage in Patients with Poor Cell Mediated Immunity\",\"authors\":\"J. King, J. Caplehorn, J. Seifert, A. Preketes, P. Clingan, D. Morris\",\"doi\":\"10.1080/14759560290032746\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":100490,\"journal\":{\"name\":\"ESMO Gastrointestinal Oncology\",\"volume\":\"91 6 1\",\"pages\":\"39-44\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ESMO Gastrointestinal Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/14759560290032746\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ESMO Gastrointestinal Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/14759560290032746","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}